PEP (Post-Exposure Prophylaxis)

Post-Exposure Prophylaxis (PEP)

PEP is a short-term medication regimen taken by individuals who have been potentially exposed to HIV within the past 72 hours. It involves taking a combination of antiretroviral drugs for 28 days to reduce the risk of HIV infection after exposure. PEP is typically recommended in emergency situations such as condom breakage during sex or needle-sharing among injection drug users. It's crucial to start PEP as soon as possible after exposure for maximum effectiveness.

Who Should Consider Taking PEP?
PEP (Post-Exposure Prophylaxis) should be considered by individuals who have been recently exposed to HIV within the past 72 hours.

This includes individuals who:
Have had unprotected sex with a partner known to be HIV-positive or of unknown HIV status.
Have had condom breakage during sexual intercourse.
Have shared injection drug equipment with a person living with HIV.
Experience occupational exposure to HIV, such as needlestick injuries among healthcare workers.

Side Effects and Interactions
Post-Exposure Prophylaxis (PEP) drugs are used to prevent HIV transmission after a possible exposure. However, these drugs may have some side effects, which include nausea, vomiting, fatigue, diarrhea, headaches, dizziness, skin rash, abdominal discomfort, and changes in liver enzyme levels. Although these side effects are usually mild and temporary, individuals undergoing PEP should promptly report any adverse reactions to their healthcare provider for monitoring and possible adjustments to the treatment regimen.